Functional and histological assessment of an experimental model of takotsubo's cardiomyopathy

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Sachdeva, Jaspreet ^a   Dai, Wangde ^a   Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Electron microscopy; Histopathology; Isoproterenol; Takotsubo cardiomyopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FAT DROPLET; ISOPRENALINE; METOPROLOL; PROPRANOLOL;

AKINESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL VACUOLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; ECHOCARDIOGRAPHY; EDEMA; EXPERIMENTAL MODEL; FUNCTIONAL STATUS; FUNCTIONAL STATUS ASSESSMENT; HEART LEFT VENTRICLE SIZE; HISTOPATHOLOGY; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR; TAKOTSUBO CARDIOMYOPATHY; TISSUE NECROSIS; TREATMENT RESPONSE; ULTRASOUND TRANSDUCER; ULTRASTRUCTURE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; ECHOGRAPHY; ELECTRON MICROSCOPY; FIBROSIS; HEART; HEART MUSCLE; HEMODYNAMICS; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FIBROSIS; HEART; HEMODYNAMICS; MALE; METOPROLOL; MICROSCOPY, ELECTRON; MYOCARDIUM; NECROSIS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; TAKOTSUBO CARDIOMYOPATHY;

EID: 84925633393     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000921     Document Type: Article

References (18)

1. Yatsinyuk BB. Hemodynamic disturbances and activation of lipid peroxidation in the pathogenesis of acute myocardial injury induced by propranolol in toxic doses. Bull Exp Biol Med. 2011;151:308-310.
2. Owczarek J, Jasińska M, Orszulak-Michalak D. Interaction between different doses of simvastatin after two-week administration and metoprolol injection on the heart rate in normocholesterolemic rats. Acta Pol Pharm. 2008;65:141-145.
3. Kloner RA, Ganote CE, Whalen DA, Jr, Jennings RB. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol. 1974;74:399-422.
4. Ellison GM, Torella D, Karakikes I, Purushothaman S, Curcio A, Gasparri C, Indolfi C, Cable NT, Goldspink DF, Nadal-Ginard B. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem. 2007;282: 11397-11409.
5. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118:2754-2762.
6. Wittstein IS. Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning? Cell Mol Neurobiol. 2012;32:847-857.
7. Shao Y, Redfors B, Scharin Täng M, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E. Novel rat model reveals important roles of badrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol. 2013;168: 1943-1950.
8. Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P, Stuckey DJ, Nikolaev VO, Diakonov I, Pannell L, Gong H, Sun H, Peters NS, Petrou M, Zheng Z, Gorelik J, Lyon AR, Harding SE. High levels of circulating epinephrine trigger apical cardiodepression in a b2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126:697-706.
9. Elsokkari I, Cala A, Khan S, Hill A. Takotsubo cardiomyopathy: not always innocent or predictable. A unique post mortem insight. Int J Cardiol. 2013;167: e46-e48.
10. Iacucci I, Carbone I, Cannavale G, Conti B, Iampieri I, Rosati R, Sardella G, Frustaci A, Fedele F, Catalano C, Francone M. Myocardial oedema as the sole marker of acute injury in Takotsubo cardiomyopathy: a cardiovascular magnetic resonance (CMR) study. Radiol Med. 2013;118:1309-1323.
11. Shao Y, Redfors B, Stàhlman M, Täng MS, Miljanovic A, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E. A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. Eur J Heart Fail. 2013;15:9-22.
12. Ibrahim T, Nekolla SG, Langwieser N, Rischpler C, Groha P, Laugwitz KL, Schwaiger M. Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome: a variant of Takotsubo cardiomyopathy. Circulation. 2012;126: e324-e326.
13. Mori H, Ishikawa S, Kojima S, Hayashi J, Watanabe Y, Hoffman JI, Okino H. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res. 1993 Feb;27:192-198.
14. Izumi Y, Okatani H, Shiota M, Nakao T, Ise R, Kito G, Miura K, Iwao H. Effects of metoprolol on epinephrine-induced takotsubo-like left ventricular dysfunction in non-human primates. Hypertens Res. 2009;32:339-346.
15. Ishikura F, Takano Y, Ueyama T. Acute effects of beta-blocker with intrinsic sympathomimetic activity on stress-induced cardiac dysfunction in rats. J Cardiol. 2012;60:470-474.
16. Palla AR, Dande AS, Petrini J, Wasserman HS, Warshofsky MK. Pretreatment with low-dose b-adrenergic antagonist therapy does not affect severity of Takotsubo cardiomyopathy. Clin Cardiol. 2012;35:478-481.
17. Kyuma M, Tsuchihashi K, Shinshi Y, Hase M, Nakata T, Ooiwa H, Abiru M, Hikita N, Adachi T, Shoji T, Fujise Y, Shimamoto K. Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy): three cases. Circ J. 2002;66:1181-1184.
18. Yoshioka T, Hashimoto A, Tsuchihashi K, Nagao K, Kyuma M, Ooiwa H, Nozawa A, Shimoshige S, Eguchi M, Wakabayashi T, Yuda S, Hase M, Nakata T, Shimamoto K. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy). Am Heart J 2008;155:526.e1-526.e7.